Posts tagged with: "Avandia" Results 481 - 500 of 886
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Aug 2010, 8:47 pm
Other health professionals have speculated that Avandia will be pulled off the market soon. [read post]
29 Jul 2010, 8:41 pm by Ed Wallis
Glaxo has set aside a total of $2.4 billion to settle various lawsuits involving Paxil and the company’s diabetes drug Avandia. [read post]
28 Jul 2010, 4:50 pm by Colin O'Keefe
- Management consultant Cliff Mintz of BioInsights Inc. in his Bio Job Blog Was the FDA Advisory Panel on Avandia Tainted by Conflict? [read post]
27 Jul 2010, 6:52 pm
Drugs like Vioxx, Ketek and now Avandia are looming large in the new debate. [read post]
26 Jul 2010, 8:42 am by Oklahoma City Attorney
Avandia is a diabetes drug that's manufactured by GlaxoSmithKline, and it's come under intense scrutiny in recent years because of the high number of reports of Avandia side effects that have developed. [read post]
26 Jul 2010, 7:29 am
Avandia is developed and manufactured by GlaxoSmithKline. [read post]
23 Jul 2010, 8:23 pm
 During the meeting of 33 panel members, 12 voted Avandia should be withdrawn; 10 voted its sales should be restricted and warning labels enhanced; 7 voted solely for enhanced warning labels; and 3 voted to keep Avandia on the market with no changes to its warnings. [read post]
23 Jul 2010, 2:43 am by Bob Kraft
The Food and Drug Administration has ordered GlaxoSmithKline to stop enrolling people in a controversial clinical trial comparing diabetes drugs, and to notify more than 1,300 people already undergoing tests that they may be at greater risk for heart attacks because they have taken Avandia. [read post]
22 Jul 2010, 4:23 pm by Mark Zamora
But the agency is demanding that GlaxoSmithKline update physicians and ethics oversight boards involved in the trial regarding all new safety information about the drug.We are investigating claims regarding Avandia. [read post]
22 Jul 2010, 9:55 am
Sources: Diabetes Drug Maker Hid Test Data, Files Indicate Glaxo to Take a Major Charge FDA Panel Says Keep Avandia on Market Avandia Wins Market Reprieve [read post]
22 Jul 2010, 8:37 am
As a Florida Avandia claims lawyer who represents consumers injured by the Diabetes drug Avandia, I was pleased to learn that GlaxoSmithKline issued a statement that they were halting the recruitment of patients for a so called TIDE trial. [read post]
22 Jul 2010, 8:37 am
As a Florida Avandia claims lawyer who represents consumers injured by the Diabetes drug Avandia, I was pleased to learn that GlaxoSmithKline issued a statement that they were halting the recruitment of patients for a so called TIDE trial. [read post]
21 Jul 2010, 7:22 am by Carey, Danis & Lowe
It's unclear why the FDA wants to keep Avandia on the market, but it’s clear why GlaxoSmithKline, Avandia's maker, might be interested in doing so. [read post]
21 Jul 2010, 1:30 am by Dr. Shezad Malik
’s biggest drugmaker, said July 15 they set aside $2.4 billion to resolve litigation over Paxil and its Avandia diabetes drug. [read post]
19 Jul 2010, 9:11 pm by Dr. Shezad Malik
Legal News Tags, attorney Avandia heart attacks, attorney Avandia, Wrongful death Avandia, Cardiac Failure Avandia, Dallas Avandia attorney, Dallas Avandia law firm, Dallas Avandia side effect attorney, Southlake Avandia wrongful death attorney, Keller Heart Failure Avandia attorney, Grapevine Avandia Heart Failure attorney, Austin Avandia attorney, Dallas Avandia mdl, Fort Worth… [read post]
19 Jul 2010, 5:35 pm by Oklahoma City Attorney
  Unfortunately for many people, reports of serious Avandia side effects eventually began to surface, drawing the attention of Avandia side effects lawyers across the country and the FDA. [read post]
19 Jul 2010, 9:02 am by Jeff Sovern
Jeff Gelles has an interesting column, Financial reform, Avandia controversy expose problems in a market economy, comparing the causes of the financial crisis with the Avandia controversy. [read post]
19 Jul 2010, 7:00 am
Zambri, founding partner      The FDA has not yet removed Avandia from the market, although it is still considering its options. [read post]